In a report published Thursday, Nomura analyst Steven Chubak initiated coverage on Bank of America Corp. BAC at Buy, with a $19.00 price target.
According to the report, multi-year capital / cost initiatives have prepared BAC for a tougher capital regime, and its strong position supports meaningfully higher payouts vs. peers.
“ BAC's current business mix, improving efficiency, and higher rate sensitivity should support ~15% mid-cycle returns (on required capital) by 2016. Legal costs should remain elevated, but analysis suggests BAC is only moderately under-reserved for remaining Private Label exposure,” the report said.
Some highlights from the report included:
-Long-term ROE potential of ~15% supports TP of $19, or 14% potential upside.
-FY13E EPS at $0.89.
-FY14E EPS at $1.27.
BAC closed Wednesday at $16.70.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in